These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 27729459)

  • 1. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum.
    Hulbert A; Jusue-Torres I; Stark A; Chen C; Rodgers K; Lee B; Griffin C; Yang A; Huang P; Wrangle J; Belinsky SA; Wang TH; Yang SC; Baylin SB; Brock MV; Herman JG
    Clin Cancer Res; 2017 Apr; 23(8):1998-2005. PubMed ID: 27729459
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules.
    Chen C; Huang X; Yin W; Peng M; Wu F; Wu X; Tang J; Chen M; Wang X; Hulbert A; Brock MV; Liu W; Herman JG; Yu F
    Clin Epigenetics; 2020 Mar; 12(1):39. PubMed ID: 32138766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non-Small Cell Lung Cancer.
    Liu B; Ricarte Filho J; Mallisetty A; Villani C; Kottorou A; Rodgers K; Chen C; Ito T; Holmes K; Gastala N; Valyi-Nagy K; David O; Gaba RC; Ascoli C; Pasquinelli M; Feldman LE; Massad MG; Wang TH; Jusue-Torres I; Benedetti E; Winn RA; Brock MV; Herman JG; Hulbert A
    Clin Cancer Res; 2020 Aug; 26(16):4339-4348. PubMed ID: 32430478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
    Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
    Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
    [No Abstract]   [Full Text] [Related]  

  • 5. P16
    Tuo L; Sha S; Huayu Z; Du K
    Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation Between RASSF1A Gene Promoter Hypermethylation in Serum or Sputum and Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.
    Zhang Z; Yan S; Cui H; Chen H; Liu J
    Med Sci Monit; 2019 Jul; 25():5518-5524. PubMed ID: 31342946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years.
    Hubers AJ; Heideman DA; Duin S; Witte BI; de Koning HJ; Groen HJ; Prinsen CF; Bolijn AS; Wouters M; van der Meer SE; Steenbergen RD; Snijders PJ; Uyterlinde A; Berkhof H; Smit EF; Thunnissen E
    J Clin Pathol; 2017 Mar; 70(3):250-254. PubMed ID: 27496969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers.
    Guzmán L; Depix MS; Salinas AM; Roldán R; Aguayo F; Silva A; Vinet R
    Diagn Pathol; 2012 Jul; 7():87. PubMed ID: 22818553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Methylation Biomarkers in Sputum and Plasma as Predictors for Lung Cancer Recurrence.
    Belinsky SA; Leng S; Wu G; Thomas CL; Picchi MA; Lee SJ; Aisner S; Ramalingam S; Khuri FR; Karp DD
    Cancer Prev Res (Phila); 2017 Nov; 10(11):635-640. PubMed ID: 28904059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXA9 gene promotor methylation and copy number variation of SOX2 and HV2 genes in cell free DNA: A potential diagnostic panel for non-small cell lung cancer.
    Abou-Zeid A; Hashad D; Baess A; Mosaad M; Tayae E
    BMC Cancer; 2023 Apr; 23(1):329. PubMed ID: 37038139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
    Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
    Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers.
    Yu L; Todd NW; Xing L; Xie Y; Zhang H; Liu Z; Fang H; Zhang J; Katz RL; Jiang F
    Int J Cancer; 2010 Dec; 127(12):2870-8. PubMed ID: 21351266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An epigenetic classifier for early stage lung cancer.
    Su Y; Fang HB; Jiang F
    Clin Epigenetics; 2018; 10():68. PubMed ID: 29796119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection.
    Su Y; Fang H; Jiang F
    Clin Epigenetics; 2016; 8():109. PubMed ID: 27777637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum microRNA profiling: a novel approach for the early detection of non-small cell lung cancer.
    Roa WH; Kim JO; Razzak R; Du H; Guo L; Singh R; Gazala S; Ghosh S; Wong E; Joy AA; Xing JZ; Bedard EL
    Clin Invest Med; 2012 Oct; 35(5):E271. PubMed ID: 23043708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining a gene promoter methylation signature in sputum for lung cancer risk assessment.
    Leng S; Do K; Yingling CM; Picchi MA; Wolf HJ; Kennedy TC; Feser WJ; Baron AE; Franklin WA; Brock MV; Herman JG; Baylin SB; Byers T; Stidley CA; Belinsky SA
    Clin Cancer Res; 2012 Jun; 18(12):3387-95. PubMed ID: 22510351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
    Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
    Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Indirect Efficacy Comparison of DNA Methylation in Sputum for Early Screening and Auxiliary Detection of Lung Cancer: A Meta-Analysis.
    Liu D; Peng H; Sun Q; Zhao Z; Yu X; Ge S; Wang H; Fang H; Gao Q; Liu J; Wu L; Song M; Wang Y
    Int J Environ Res Public Health; 2017 Jun; 14(7):. PubMed ID: 28644424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation analysis in plasma for early diagnosis in lung adenocarcinoma.
    Jin Y; Lu R; Liu F; Jiang G; Wang R; Zheng M
    Medicine (Baltimore); 2024 Jul; 103(28):e38867. PubMed ID: 38996143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR.
    Ostrow KL; Hoque MO; Loyo M; Brait M; Greenberg A; Siegfried JM; Grandis JR; Gaither Davis A; Bigbee WL; Rom W; Sidransky D
    Clin Cancer Res; 2010 Jul; 16(13):3463-72. PubMed ID: 20592015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.